mannose has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 4 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, K; Dong, W; He, J; Lei, QY; Lin, M; Lv, L; Tian, T; Xu, Y; Yang, Y; Zhang, R; Zhang, S; Zhang, X | 1 |
| Baltazar, F; Bañobre-López, M; Costa Da Silva, M; Costa, M; Cui, Z; Gallo, J; Genicio, N; Hanafy, MS; Oliveira-Pinto, S; Scialla, S; Wang, JL | 1 |
| Cai, Y; Chen, G; Li, B; Li, T; Lin, M; Shuai, X; Xiao, Z; Zhong, H | 1 |
| Jing, Z; Li, Y; Song, J; Zang, X | 1 |
4 other study(ies) available for mannose and ER-Negative PR-Negative HER2-Negative Breast Cancer
| Article | Year |
|---|---|
D-mannose facilitates immunotherapy and radiotherapy of triple-negative breast cancer via degradation of PD-L1.
Topics: AMP-Activated Protein Kinases; Animals; B7-H1 Antigen; Cell Line, Tumor; Female; Humans; Immunologic Factors; Immunotherapy; Lymphocytes, Tumor-Infiltrating; Mannose; Mice; Mice, Inbred BALB C; Phosphorylation; Proteolysis; Radiotherapy; T-Lymphocytes; Triple Negative Breast Neoplasms | 2022 |
Targeted treatment of triple-negative-breast cancer through pH-triggered tumour associated macrophages using smart theranostic nanoformulations.
Topics: Animals; Cell Line, Tumor; Doxorubicin; Humans; Hydrogen-Ion Concentration; Hyperthermia, Induced; Lipids; Mannose; Mice; Nanoparticles; Polyethylene Glycols; Precision Medicine; Theranostic Nanomedicine; Triple Negative Breast Neoplasms; Tumor Microenvironment; Tumor-Associated Macrophages | 2023 |
A hierarchical tumor-targeting strategy for eliciting potent antitumor immunity against triple negative breast cancer.
Topics: Animals; B7-H1 Antigen; Cell Line, Tumor; Humans; Interferons; Mannose; Matrix Metalloproteinase 2; Mice; Triple Negative Breast Neoplasms; Tumor Microenvironment | 2023 |
Efficient TNBC immunotherapy by dual reprogramming tumor-infiltrating dendritic cells and tumor-associated macrophages with stimulus-responsive miR155 nanocomplexes.
Topics: Animals; Cell Line, Tumor; Dendritic Cells; Humans; Immunotherapy; Macrophages; Mannose; Mice; MicroRNAs; Reactive Oxygen Species; Triple Negative Breast Neoplasms; Tumor Microenvironment; Tumor-Associated Macrophages | 2023 |